论文部分内容阅读
Recent advances in the understanding of biomolecular nano-sized aggregates facilitated advanced encapsulation and targeted delivery of the therapeutic agents to the disease affected tissues.We have shown pre-designed nano-sized aggregates could interact with biofluids such as blood and intestine secretions,which develops into a ligand-enriched corona that would preferentially absorbed by specific receptors or extracellular proteins that are enriched in the targeted tissues.